Renaissance Technologies
SCMP

Renaissance Technologies’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Renaissance Technologies’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,957,600
Closed -$35.1M – 3742
2017
Q4 		$35.1M Buy
1,957,600
+651,900
+50% +$8.03M 0.04% 608
2017
Q3 		$15.4M Buy
1,305,700
+495,100
+61% +$5.55M 0.02% 1055
2017
Q2 		$8.51M Sell
810,600
-300,800
-27% -$3.07M 0.01% 1376
2017
Q1 		$12.2M Sell
1,111,400
-348,400
-24% -$4.04M 0.02% 1109
2016
Q4 		$19.8M Buy
1,459,800
+106,800
+8% +$1.49M 0.03% 792
2016
Q3 		$16.7M Buy
1,353,000
+245,300
+22% +$2.89M 0.03% 814
2016
Q2 		$12.2M Buy
1,107,700
+282,000
+34% +$3.16M 0.02% 1016
2016
Q1 		$9.03M Buy
825,700
+270,900
+49% +$3.42M 0.02% 1216
2015
Q4 		$9.59M Buy
554,800
+112,700
+25% +$2.02M 0.02% 1018
2015
Q3 		$8.79M Buy
442,100
+108,000
+32% +$2.48M 0.02% 1015
2015
Q2 		$5.49M Buy
334,100
+110,386
+49% +$1.91M 0.01% 1379
2015
Q1 		$3.48M Buy
223,714
+164,914
+280% +$2.56M 0.01% 1596
2014
Q4 		$840K Buy
+58,800
New +$621K ﹤0.01% 2208
2014
Q1 		– Sell
-36,000
Closed -$338K – 3132
2013
Q4 		$338K Sell
36,000
-91,800
-72% -$655K ﹤0.01% 2475
2013
Q3 		$797K Sell
127,800
-107,200
-46% -$670K ﹤0.01% 2110
2013
Q2 		$1.55M Buy
+235,000
New +$1.86M ﹤0.01% 1724

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Renaissance Technologies's SCMP Position: Q1 2018 in Review

Renaissance Technologies sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 1,957,600 shares — an estimated $35.1M sold.

Renaissance Technologies first reported a position in SCMP in Q2 2013 and held it in 16 quarters. The position peaked at $35.1M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Renaissance Technologies reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Renaissance Technologies sold 1,957,600 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $35.1M.
  • Renaissance Technologies first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
  • Renaissance Technologies's Sucampo Pharmaceuticals, Inc. position peaked at $35.1M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.